Literature DB >> 16487614

Stabilizing of plasmid DNA in vivo by PEG-modified cationic gold nanoparticles and the gene expression assisted with electrical pulses.

Takahito Kawano1, Masato Yamagata, Hironobu Takahashi, Yasuro Niidome, Sunao Yamada, Yoshiki Katayama, Takuro Niidome.   

Abstract

This study aimed to investigate the benefits of combining the use of PEG-modified cationic gold nanoparticles with electroporation for in vivo gene delivery. PEG-modified cationic gold nanoparticles were prepared by NaBH(4) reduction of HAuCl(4) in the presence of 2-aminoethanethiol and mPEG-SH. Zeta-potential of the particles was nearly neutral (+0.1 mV). After forming complexes with plasmid DNA at a w/w ratio of 8.4, nanoparticle complexes were 90 nm for at least 60 min and showed a negative zeta-potential. After intravenous injection of DNA-nanoparticle complexes, 20% of gold were detected in blood at 120 min after injection and 5% of DNA were observed in blood after 5 min, suggesting that PEG-modified nanoparticles were stably circulating in the blood flow, but some of the DNA bound to particles degraded during circulation. When electroporation was applied to a lobe of the liver following injection of DNA-nanoparticle complexes, significant gene expression was specifically observed in the pulsed lobe. We concluded that PEG-modified nanoparticles maintained DNA more stably in the blood flow than in the case of naked DNA and electroporation assisted in restricted gene expression of circulating DNA in limited areas of the liver.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16487614     DOI: 10.1016/j.jconrel.2005.12.022

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  25 in total

1.  FUNCTIONAL NANOPARTICLES FOR MOLECULAR IMAGING GUIDED GENE DELIVERY.

Authors:  Gang Liu; Magdalena Swierczewska; Seulki Lee; Xiaoyuan Chen
Journal:  Nano Today       Date:  2010-12-01       Impact factor: 20.722

Review 2.  Utilization of monoclonal antibody-targeted nanomaterials in the treatment of cancer.

Authors:  Daniel C Julien; Steven Behnke; Guankui Wang; Gordon K Murdoch; Rodney A Hill
Journal:  MAbs       Date:  2011-09-01       Impact factor: 5.857

3.  Discovery of metabolically stabilized electronegative polyacridine-PEG peptide DNA open polyplexes.

Authors:  Christian A Fernandez; Nicholas J Baumhover; Kevin Anderson; Kevin G Rice
Journal:  Bioconjug Chem       Date:  2010-04-21       Impact factor: 4.774

Review 4.  Monolayer coated gold nanoparticles for delivery applications.

Authors:  Subinoy Rana; Avinash Bajaj; Rubul Mout; Vincent M Rotello
Journal:  Adv Drug Deliv Rev       Date:  2011-09-06       Impact factor: 15.470

Review 5.  Advances in polymeric and inorganic vectors for nonviral nucleic acid delivery.

Authors:  Joel C Sunshine; Corey J Bishop; Jordan J Green
Journal:  Ther Deliv       Date:  2011-04

Review 6.  Bioengineered nanoparticles for siRNA delivery.

Authors:  Kristen L Kozielski; Stephany Y Tzeng; Jordan J Green
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2013-07-02

Review 7.  Drug delivery strategies for therapeutic angiogenesis and antiangiogenesis.

Authors:  Nupura S Bhise; Ron B Shmueli; Joel C Sunshine; Stephany Y Tzeng; Jordan J Green
Journal:  Expert Opin Drug Deliv       Date:  2011-02-22       Impact factor: 6.648

Review 8.  Therapeutic nanomedicine for brain cancer.

Authors:  Stephany Y Tzeng; Jordan J Green
Journal:  Ther Deliv       Date:  2013-06

Review 9.  Use of nanoparticles to deliver immunomodulatory oligonucleotides.

Authors:  Dennis M Klinman; Takashi Sato; Takeshi Shimosato
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2015-12-12

Review 10.  Nanoparticulate systems for polynucleotide delivery.

Authors:  Ashwin Basarkar; Jagdish Singh
Journal:  Int J Nanomedicine       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.